B. Lall Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.90 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 M
- Revenue Growth 142.37%
- Profit Growth 58.49%
- Ebitda 167.23%
- Net Worth 67.20%
- Total Assets 60.88%
About B. Lall Pharma
B. Lall Pharma Private Limited (BLPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 2020 (Five years and two months 1 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹1.70 M.
Anil Mediratta, Rohit Mediratta, and Sunil Mediratta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230DL2020PTC363122
- Company No.
363122
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Chemicals and Materials
B. Lall Pharma Private Limited
Explore comprehensive data for B. Lall Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at B. Lall Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Mediratta  | Director | 01-Apr-2020 | Current |
| Rohit Mediratta | Director | 01-Apr-2020 | Current |
| Sunil Mediratta | Director | 01-Apr-2020 | Current |
Financial Performance of B. Lall Pharma.
B. Lall Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 142.37% increase. The company also saw a substantial improvement in profitability, with a 58.49% increase in profit. The company's net worth Soared by an impressive increase of 67.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B. Lall Pharma?
Unlock access to B. Lall Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Veritas Life Sciences Limited
Anil Mediratta is a mutual person
- Pharmasys Private Limited
Anil Mediratta is a mutual person
- Generica India Limited
Anil Mediratta is a mutual person
Charges (Loans)
Open Charges
₹1.70 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2022 | Others | ₹1.70 M | Open |
How Many Employees Work at B. Lall Pharma?
B. Lall Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B. Lall Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B. Lall Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on B. Lall Pharma
Recent activity within the organization
- Annual General Meeting
B. Lall Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
B. Lall Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Others amounted to Rs. 1.70 M with Charge ID 100645561 was registered on 03 Dec 2022.
- Director Appointment
Anil Mediratta was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 2 months .
- Director Appointment
Rohit Mediratta was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 2 months .
- Director Appointment
Sunil Mediratta was appointed as a Director was appointed as a Director on 01 Apr 2020 & has been associated with this company since 5 years 2 months .
Frequently asked questions
What is the Incorporation or founding date of B. Lall Pharma Private Limited?
B. Lall Pharma Private Limited was incorporated on 01 Apr 2020.
What is authorized share capital and paid-up capital of B. Lall Pharma Private Limited?
The authorized share capital of B. Lall Pharma Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.90 M.
Who are the current board members & directors of B. Lall Pharma Private Limited?
Currently 3 directors are associated with B. Lall Pharma Private Limited.
- Anil Mediratta
- Rohit Mediratta
- Sunil Mediratta
What is the registered address of B. Lall Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of B. Lall Pharma Private Limited is 1581/3-4 Bhagirath Palace Chandani Chowk India, Delhi, 110006.
What is the corporate identification number (CIN) and company number of B. Lall Pharma Private Limited?
The corporate identification number (CIN) of B. Lall Pharma Private Limited is U24230DL2020PTC363122 and the company number is 363122 as per Ministry of Corporate Affairs (MCA).
What is the official website of B. Lall Pharma Private Limited?
The Official website of B. Lall Pharma Private Limited is https://www.blall.in
What has been the recent revenue trend for B. Lall Pharma Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for B. Lall Pharma Private Limited has risen by 142.37%.
What change has been observed in the net worth of B. Lall Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of B. Lall Pharma Private Limited has experienced an upsurge of 67.20%.
What are the total open charges for B. Lall Pharma Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for B. Lall Pharma Private Limited amount to ₹ 1.70 M.
When was the last Balance Sheet of B. Lall Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for B. Lall Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records